Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Oct 31;22(1):623.
doi: 10.1186/s12887-022-03704-5.

Chemotherapy induced juvenile dermatomyositis: a novel presentation- a case report

Affiliations
Case Reports

Chemotherapy induced juvenile dermatomyositis: a novel presentation- a case report

Keta Vagha et al. BMC Pediatr. .

Abstract

Background: Idiopathic connective tissue disease juvenile dermatomyositis (JDM) is characterised by inflammatory myositis and distinctive skin abnormalities. Only a few cases of Dermatomyositis (DM) owing to chemotherapy used to treat cancer have been reported, despite the fact that the link between DM and cancer in adults is widely known. We describe the case of a female, age 14, who experienced DM as a side effect of chemotherapy following enucleation for retinoblastoma. We also discussed our patient's likely pathophysiology of JDM after treatment.

Case presentation: A 14-year-old female came to our facility complaining of trouble walking and bluish-black discoloration on her neck, elbows, forehead, and knees that had been present for eight months. The patient had undergone enucleation of the left eye due to retinoblastoma, followed by 40 cycles of radiation therapy and 13 cycles of chemotherapy with Cyclophosphamide, Etoposide, Carboplatin, Vincristine, and Dactinomycin. Her serum LDH and CPK levels were high, and she tested positive for ANA. The muscle biopsy was consistent with the changes of DM. When electromyography was performed, it revealed tiny, fibrillating, polyphasic motor unit potentials and sharp, positive waves that were suggestive with DM. A diagnosis of JDM was made after taking into account the symptoms, biochemical data, muscle biopsy, and electromyography results. The patient's symptoms started to get better once methotrexate and oral corticosteroids were started.

Conclusion: This case report emphasises the value of ongoing observation after cancer chemotherapy because specific cutaneous and muscle symptoms may lead paediatricians to consider the possibility of chemotherapy-induced JDM, which is uncommon in young patients.

Keywords: Chemotherapy; Dermatomyositis; Inflammatory myositis; Malignancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
A and B show the lichenified plaques in the right and left axilla
Fig. 2
Fig. 2
A The V neck sign/Shawl sign on the neck and upper chest. B Heliotrope rash with erythema over the face, Arrow represents the site of enucleation. C Gottron’s papules over the digits which are in the healing stage. D Pearly white lesion on the extensor aspect of the elbow showing Calcinosis cutis
Fig. 3
Fig. 3
Given section stained with Hematoxylin and Eosin (low power view: 10x) shows fibroadipose tissue, blood vessels and chronic inflammatory response around the blood vessels (perivascular). Muscle fibres in the dermis appear necrosed and fragmented
Fig. 4
Fig. 4
Potential pathogenesis of malignancy associated DM
Fig. 5
Fig. 5
Evaluation of Response to therapy in JDM

References

    1. Oddis CV, Conte CG, Steen VD, Medsger TA., Jr Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963–1982. J Rheumatol. 1990;17(10):1329–1334. - PubMed
    1. Olazagasti JM, Baez PJ, Wetter DA, Ernste FC. Cancer risk in dermatomyositis: a meta-analysis of cohort studies. Am J Clin Dermatol. 2015;16:89–98. doi: 10.1007/s40257-015-0120-1. - DOI - PubMed
    1. Bottai M, Tjärnlund A, Santoni G, et al. EULAR/ ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open. 2017;3:e000507. doi: 10.1136/rmdopen-2017-000507. - DOI - PMC - PubMed
    1. Bohan A, Peter JB. Polymyositis and Dermatomyositis. N Engl J Med. 1975;292:344–347. doi: 10.1056/NEJM197502132920706. - DOI - PubMed
    1. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357:96–100. doi: 10.1016/S0140-6736(00)03540-6. - DOI - PubMed

Publication types

Substances

LinkOut - more resources